BALB／c小鼠胚胎干细胞系的建立及其嵌合体小鼠的获得

目的：建立BALB/c小鼠胚胎干细胞系,并用于制作嵌合体小鼠。方法：从BALB／c小鼠囊胚内分离培养内细胞团块。建系后,进行C57BL／6L小鼠受体囊胚腔注射,制作嵌合体小鼠,结果：建立了我国第一株BALB／c小鼠胚胎干细胞系,该细胞系具有典型的ES细胞形态,碱性磷酸酶强阳性,核型正常以及具有分化为三种胚层组织的能力,并已产生5只嵌合体小鼠,结论：建立的BALB／c小鼠胚胎干细胞系具有胚胎干细胞的各种特点,可用于体内外诱导分化研究,在进一步观察生殖系嵌合情况后,决定是否可应用于基因打靶等转基因动物的制作。     

创建干细胞而不损伤正常胚胎

有2个独立的研究组设计了几种方法来分离小鼠的胚胎干细胞,而不破坏活的胚胎.这些方法打算满足人们的伦理关切,因为有些人反对破坏人的胚胎来进行科研或治疗疾病.与成人干细胞不同的是,胚胎干细胞可以在形态结构上形成任何体细胞类型,诸如神经、肌肉或是心脏.许多研究者建议,利用胚胎干细胞的独特性能来制造新细胞,用以治疗损伤或是疾病,诸如帕金森病.然而,为了分离出新的胚胎干细胞系,科学家已经首次破坏了早期胚胎.为了既要拯救生命又要关注生命被破坏,研究者注意到,通常用来诊断胚胎遗传病的一项技术.该技术称为基因诊断前移植,即从8个细…     

小鼠胚胎干细胞(ES-8501细胞)建系过程的核型及特性分析

小鼠胚胎性癌(EC)细胞系的细胞核型大多数异常,对用于分析EC细胞与胚胎细胞之间的关系和进行嵌合体研究等都是不利的。人们都期望能有正常核型的胚胎细胞系的建立。近年来Evans和Kaufman以及Martin等人先后用不同方法直接从小鼠的内细胞团(ICM)细胞建立了多潜能的胚胎干细胞(erabryonicstem eells,简称ES细胞),也有人称之为EK     

源于129S1品系的小鼠胚胎干细胞系的建立及其生物学特性分析

从129S1小鼠早期胚胎的内细胞团分离、培养类胚胎样细胞,经反复传代,成功地建立了129S1小鼠胚胎干细胞系,命名为NM-2细胞系。形态学鉴定具有胚胎干细胞的典型形态特征,正常核型率为80％;呈碱性磷酸酶阳性、表达胚胎干细胞特异性转录因子OCT-4;体内分化后可形成源于三胚层的组织结构;经囊胚腔显微注射后所获得的子代个体中79％具有毛色嵌合表型;雄性嵌合个体中31％发生生殖腺嵌合;同时,通过育种观察到所有生殖腺嵌合体的子代小鼠表型正常。以上结果证实NM-2细胞系为一株具高生殖腺嵌合能力的小鼠胚胎干细胞系。     

小鼠孤雌胚胎干细胞系的建立及生物学特性鉴定

目的:探讨建立合适的小鼠孤雌胚胎干细胞建系方法。方法:采用氯化锶联合细胞松弛素B激活B6D2F1杂交小鼠卵母细胞,所获得的囊胚与桑椹胚分别用于孤雌胚胎干细胞的建系,观察两者的建系成功率。结果:共建立了12株小鼠孤雌胚胎干细胞系,这些细胞SSEA-1抗原阳性,SSEA-4,TRA-1-81,TRA-1-60表面抗原阴性,具有AKP活性,保持正常染色体核型,体内外分化分别形成畸胎瘤和拟胚体。结论:采用囊胚和去透明带的桑葚胚建立孤雌胚胎干细胞系获得成功。该方法为人类纯合子的胚胎干细胞建系提供基础,在自体细胞治疗领域中具有潜在的应用价值。     

基础培养液和小分子对猪类胚胎干细胞建系效率的影响

猪是人类疾病模型的重要候选动物之一,建立真正的猪胚胎干细胞系将极大地推动该领域的进展。培养液和细胞信号通路是目前限制猪胚胎干细胞系建立的两个主要影响因素。该研究探索了基础培养液(KO-DMEM和DMEM/F12)和小分子(PD0325901和CHIR99021,简称2i)对猪类胚胎干细胞建系效率的影响。实验结果显示,发育至6 d的体外受精胚胎在KO-DMEM培养液中贴壁率和原代克隆形成率显著高于DMEM/F12培养液;添加2i后,两种培养液中的胚胎贴壁率和原代克隆形成率均下降。在KO-DMEM培养液中可获得稳定传代的细胞系,获得的细胞系呈碱性磷酸酶阳性,核型正常,表达Oct4、Sox2和Nanog,不表达Cdx2。细胞系可成功进行转基因操作。结果表明,以KO-DMEM为基础培养液的培养体系可以获得猪类胚胎干细胞,2i不利于胚胎贴壁和原代克隆形成。该研究为猪胚胎干细胞建系培养体系的选择及推断猪胚胎干细胞多能性细胞信号调控通路提供了重要的实验依据。     

人胚胎干细胞向滋养层分化的研究进展

哺乳动物胚胎发育产生的第一个细胞系的分离是内细胞团和滋养层的分离,不同哺乳动物之间胚胎干细胞向滋养层细胞分化不同,滋养层细胞对胚胎的植入、促进胚胎在子宫内的生存和生长至关重要.人胚胎干细胞为研究人类胚胎发育及向滋养层分化提供了一个独特的模型.人胚胎干细胞可以在实验室条件下保持无限期稳定的培养,用于最初胚胎和滋养外胚层发生的机制研究.目前人胚胎干细胞分化为滋养层细胞在体外可以通过自发分化、基因敲除、分离EB小体和BMP4诱导等几种途径实现.不同哺乳动物之间胚胎干细胞向滋养层分化机制,主要通过信号通路如BMP4,LIF等以及某些标志基因如OCT4,CDX2,Eomes等的变化调节.人胚胎干细胞向滋养层分化的研究为临床应用提供了一定的基础.     

猪胚胎干细胞研究进展

胚胎干细胞是一类具有在体外无限自我复制和分化为体内任何种类细胞的多潜能细胞。目前,公认的胚胎干细胞全能性判断标准包括:体内及体外向三胚层细胞分化和二倍体嵌合后能形成生殖细胞。从1981年Kaufman等第一次分离小鼠胚胎干细胞至今,能满足这些标准的只有小鼠、大鼠和鸡的胚胎干细胞系。猪作为一种生理结构和器官的三维结构和人都比较相似的传统药物实验模型,其胚胎干细胞系的建立一直受到广泛的关注,但是迄今为止真正的猪胚胎干细胞系(即满足上述判定标准)还未被建立起来。本文将从多个方面阐述猪胚胎干细胞系的研究进展及亟待解决的问题。猪的全基因组序列已经测序完成,相信随着干细胞研究的深入开展,对维持多能性的转录因子和细胞信号通路认识的逐步加深,建立真正的猪胚胎干细胞系将成为可能。     

从异常核型人胚胎干细胞中筛选不同X染色体失活状态的亚系

目的:从异常核型人胚胎干细胞系中分离两种不同X染色体失活(XCI)状态的细胞,建立亚系,并进行对其XCI状态特征和多能性标记进行鉴定。方法:G显带鉴定人胚胎干细胞系ch HESC-3早晚期代数细胞的核型,H3K27me3免疫荧光染色鉴定早晚期ch HESC-3表观遗传差异,RT-PCR检测早晚期ch HESC-3中XIST基因的表达。利用单细胞克隆的培养分选亚系,H3K27me3、RNA polymeraseⅡ以及DAPI三种标记的共染后每种表观标记各选两株进行RT-PCR,检测两种亚系中XIST基因的表达。并对这四株细胞进行干细胞标记鉴定。结果:G显带结果证明早期ch HESC-3为正常核型,晚期代数核型为异常核型,牵涉到8条染色体的复杂结构变异。H3K27me3免疫荧光染色证明异常核型ch HESC-3中有部分细胞出现了H3K27me3凝集点,而正常核型细胞中未发现。正常核型细胞(ch HESC-3N)没有XIST基因表达,异常核型细胞(ch HESC-3C)中有表达。在RNA polymeraseⅡ着色缺口中发现H3K27me3凝集点的细胞亚株XIST基因表达阳性,polymeraseⅡ着色缺口中未发现H3K27me3凝集点的细胞亚株XIST基因表达阴性,XIST阳性和阴性细胞各选两株进行多能性标记免疫荧光染色均为阳性。结论:成功从异常核型人胚胎干细胞系中分离两种不同XCI状态的细胞并建立亚系,两种表观类型的亚系均保持多能性标记并能在长期培养中保持各自特性。     

人胚胎干细胞建系的研究进展

人胚胎干细胞(human embryonic stem cells,h ESCs)具有自我更新和分化的潜能,自成功建立细胞系以来学者们一直在改进建系方法和培养体系,如避免异源污染(基质胶的研究、无饲养层和无血清培养体系的研究等)以建立优质的细胞系,获得更高全能性的干细胞(采用不同小分子的组合培养干细胞或建系),这些研究已经取得巨大成果。现通过胚胎来源、内细胞团(inner cell mass,ICM)分离、h ESCs培养体系3个方面综述h ESCs建系的研究进展。     

Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos

Although a normal karyotype is generally a requirement for stem cell lines, new applications are likely to emerge for stem cells with defined chromosomal aneuploidies. We therefore investigated the use of embryos found to be aneuploid on biopsy followed by preimplantation genetic diagnosis (PGD) with fluorescent in situ hybridization (FISH), and developmentally arrested embryos for stem cell derivation. Eleven stem cell lines were obtained from 41 embryos in 36 cultures, with higher success rate achieved from PGD-analyzed, developmentally advanced embryos (45%) than from clinically unsuitable non-PGD embryos (13%). The resulting stem cell lines were karyotyped, and surprisingly, six of the nine lines from aneuploid embryos as well as both lines from non-PGD embryos were karyotypically normal. Three lines from PGD embryos were aneuploid exhibiting trisomy 5, trisomy 16, and an isochromosome 13, respectively. None of the aneuploid lines presented the same anomally as the original PGD analysis. Our study has three important implications. First, we confirm the ability to produce stem cell lines from PGD-tested embryos as well as developmentally abnormal embryos, offering specialty stem cell lines for research into the clinically important aneuploidies. Second, we observe that stem cell derivation from apparently aneuploid embryos is often thwarted by underlying mosaicism and emerging dominance of the stem cell line by karyotypically normal cells. The corollary, however, is that regular production of normal stem cell lines from developmentally abnormal embryos ordinarity discarded opens a new source of embryos for stem cells, whether for research or for eventual therapeutic use within the donating families.     

Preimplantation genetic diagnosis in Saudi Arabia

Preimplantation genetic diagnosis (PGD) testing is the practice of obtaining a cellular biopsy sample from a developing human oocyte or embryo, acquired via a cycle of in vitro fertilization (IVF); evaluating the genetic composition of this sample; and using this information to determine which embryos will be optimal for subsequent uterine transfer. PGD has become an increasingly useful adjunct to IVF procedures. The ability to provide couples who are known carriers of genetic abnormalities the opportunity to deliver healthy babies has opened a new frontier in reproductive medicine. The purpose of the PGD is enables us to choose which embryos will be implanted into the mother. In the present study 137 families who had undergone IVF at Habib Medical Centre, were enrolled for the PGD analysis. The couple visited the clinic for the sex selection, recurrent fetal loss and with the recurrent IVF failure. 802 embryos were tested by the biopsy method and 512 are found to be normal and 290 were abnormal embryos. In this study only 24% of the embryos were transferred and the remaining was not transferred because of the abnormalities or undesired sex of the embryos. The structural and numerical abnormalities were found to be 16.8%.     

Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos

In this study, we focused on the derivation of human embryonic stem cell (hESC) from preimplantation genetic screening (PGS)-analyzed and preimplantation genetic diagnosis (PGD)-analyzed embryos. Out of 62 fresh PGD/PGS-analyzed embryos, 22 embryos reached the blastocyst stage. From 12 outgrowth blastocysts, we derived four hESC lines onto a feeder layer. Surprisingly, karyotype analysis showed that hESC lines derived from aneuploid embryos had diploid female karyotype. One hESC line was found to carry a balanced Robertsonian translocation. All the cell lines showed hESC markers and had the pluripotent ability to differentiate into derivatives of the three embryonic germ layers. The established lines had clonal propagation with 22–31% efficiency in the presence of ROCK inhibitor. These results further indicate that hESC lines can be derived from PGD/PGS-analyzed embryos that are destined to be discarded and can serve as an alternative source for normal euploid lines.     

植入前遗传学诊断的原理、方法及适应症

植入前遗传学诊断是一种非常早的产前诊断,指在胚胎着床之前即对配子或胚胎的遗传物质进行分析,检测配子或胚胎是否有遗传物质异常,选择正常胚胎进行移植。与传统的产前诊断相比,能避免选择性流产异常妊娠给妇女带来的心身痛苦。本文就该领域的发展及现状和其诊断原理、方法及适应症进行了总结和综述。 Abstract:Preimplatation genetic diagnosis (PGD) is a very early form of prenatal diagnosis.Gametes or embryos are biopsied and a genetic diagnosis is carried out on the biopsied cells to investigate if the gametes or embryos is free of genetic disease.And the normal embryos is transferred to the mother.Comparing to the traditional prenatal diagnosis,PGD is a method that can avoid aborting a abnormal pregnant and reduce pains of women.In this review,we introduce the history of development and statues in quo,principle,method and application of PGD.     

Correlation between preimplantation genetic diagnosis for chromosomal aneuploidies and the efficiency of establishing human ES cell lines

There are several sources from which human embryonic stem cell (hESC) lines can be generated: surplus embryos after in vitro fertilization procedures, one- and three-pronuclear zygotes, early arrested or highly fragmented embryos that have reached the blastocyst stage, or otherwise chromosomally or genetically abnormal embryos after preimplantation genetic diagnosis (PGD). We report on the efficiency of establishing hESC lines from blastocysts with proven meiotic or mitotic errors after sequential testing of both polar bodies and blastomere analysis on day 3. The success rate of establishing hESC lines originating from blastocysts carrying a meiotic error was as low as 2.4% and differed significantly from the success rate of establishing hESC lines originating from blastocysts with balanced meiotic errors (21.6%) or mitotic errors (after sequential testing (9.1%) and after blastomere testing alone (12.2%)). This suggests that it may be reasonable to apply sequential PGD prior to the initiation of hESC culture. Information about the karyotype may in the future help refine the methods and possibly improve the efficiency by which hESC lines are derived from embryos with prezygotic abnormalities. Additionally, it may in general prove very difficult to obtain abnormal hESC lines for scientific study from aneuploid PGD embryos, which will limit our ability to study the biological consequences of chromosomal abnormalities. Furthermore, the success rates for generating aneuploid cell lines originating from fertilized oocytes carrying a prezygotic nondisjunction error seem to mirror the miscarriage rates during pregnancy of embryos carrying such errors.     

Refining the ethics of preimplantation genetic diagnosis: A plea for contextualized proportionality

Many European countries uphold a ‘high risk of a serious condition’ requirement for limiting the scope of preimplantation genetic diagnosis (PGD). This ‘front door’ rule should be loosened to account for forms of PGD with a divergent proportionality. This applies to both ‘added PGD’ (aPGD), as an add‐on to in vitro fertilization (IVF), and ‘combination PGD’ (cPGD), for a secondary disorder in addition to the one for which the applicants have an accepted PGD indication. Thus loosening up at the front has implications at the back of PGD treatment, where a further PGD rule says that ‘affected embryos’ (in the sense of embryos with the targeted mutation or abnormality) should not be transferred to the womb. This ‘back door’ rule should be loosened to allow for transferring ‘last chance’ affected embryos in aPGD and cPGD cases, provided this does not entail a high risk that the child will have a seriously diminished quality of life.     

Human Embryonic Stem Cell Lines with Lesions in FOXP3 and NF1

Human embryonic stem cells (hESCs) are derived from the inner cell mass (ICM) of blastocyst staged embryos. Spare blastocyst staged embryos were obtained by in vitro fertilization (IVF) and donated for research purposes. hESCs carrying specific mutations can be used as a powerful cell system in modeling human genetic disorders. We obtained preimplantation genetic diagnosed (PGD) blastocyst staged embryos with genetic mutations that cause human disorders and derived hESCs from these embryos. We applied laser assisted micromanipulation to isolate the inner cell mass from the blastocysts and plated the ICM onto the mouse embryonic fibroblast cells. Two hESC lines with lesions in FOXP3 and NF1 were established. Both lines maintain a typical undifferentiated hESCs phenotype and present a normal karyotype. The two lines express a panel of pluripotency markers and have the potential to differentiate to the three germ layers in vitro and in vivo. The hESC lines with lesions in FOXP3 and NF1 are available for the scientific community and may serve as an important resource for research into these disease states.     

Human embryonic stem cells: Problems and perspectives

Generation of human embryonic stem cell lines is one of the most important achievements in biological science in the 20th century. It has excited a wide scientific and social response, as embryonic stem cells (ESC) may, in the future, be regarded as an unlimited source of transplantation materials for replacement cell therapy. ESC lines are derived, cultured, inner cell mass from human blastocysts is used in the in vitro fertilization procedure. To date, human embryonic cell lines have been obtained in more than 20 countries. In our country, embryonic stem cell research is carried out in the Institute of Cytology, Russian Academy of Sciences and the Institute of Gene Biology, Russian Academy of Sciences. Studies with human ESC go in several directions. Much attention is paid to finding the most optimal conditions for ESC cultivation, mainly to the development of cultivation techniques excluding animal feeder cells and other components of animal origin. Another direction is a large-scale analysis of gene expression specific to the embryonic state of cells and the corresponding signaling pathways. Great efforts are being focused on the directed differentiation of ESC into various tissue-specific cells. It has been shown that in vitro ESC are able to differentiate into virtually any somatic cells. Works are in progress to develop methods for “therapeutic cloning,” i.e. the transfer of somatic nuclei into enucleated oocytes or embryonic stem cell cytoblasts and their reactivation. Of great importance is the standardization of the human ESC lines. However, standard requirements for cells utilized for research or therapeutic purposes may be different. It has been found that many permanent human ESC lines underwent genetic and epigenetic variations. Therefore, the cell line genetic stability should be periodically verified. The main purpose of the review is to provide a detailed consideration of research on the genetic stability of human and mouse ESC lines. Human ESC lines established both in our country and others could not thus far be used in clinical practice. It is highly probable that undifferentiated ESCs cannot be applied for therapeutic purposes, as there is a risk of their malignant transformation. Therefore, main efforts should be focused on the production ESC progenitor and highly differentiated cells suitable for transplantation.     

荧光原位杂交探针应用于平衡易位t（1，6）（q42；p23）胚胎植入前诊断的研究

背景：染色体相互易位在人群中比较常见,下一代常常产生相同或不同的易位,易导致容易流产,而植入前诊断方法之一的CGH难以检测到相互易位,因此原位杂交（FISH）依然是解决诊断相互易位的有力手段。目的：通过设计个体化的FISH探针,制备探针,并在卵裂球单细胞水平进一步验证探针的准确性,为筛选正常核型的囊胚进行植入奠定技术基础,为个体化的FISH探针植入前诊断提供应用研究基础。方法：通过设计1 q和6p平衡易位探针,进行探针标记,再采用患者和正常人核型验证探针质量,通过荧光原位杂交技术进一步检测正常人受精后的卵裂球中1q 和6p平衡易位对易位染色体状态。结果：3个卵接球裂均呈现单个完整细胞核,荧光原位杂交中各细胞核均有清晰明亮的杂交信号。信号数分别为2。均为正常胚胎,可以考虑进一步对该易位患者进行卵裂球进行诊断,上述研究对个体化的易位探针的应用研究提供了研究基础。